"The Effectiveness of Low-Carb Diets vs. Insulin Push by the American Diabetes Association"

The American Diabetes Association (ADA) has been criticized for prioritizing insulin and pharmaceuticals over low-carb diets in the treatment of diabetes, despite evidence showing the effectiveness of low-carb diets in reversing the condition. Critics argue that the ADA's ties to pharmaceutical and food industries may influence its recommendations, leading to a lack of emphasis on diet-based approaches. The ADA's close relationship with industry has raised concerns about conflicts of interest and the organization's commitment to prioritizing the health of people with diabetes.